Mostafa Kamal

As president and CEO of Prime Therapeutics, Mostafa Kamal leads Prime and Magellan Rx as a unified pharmacy solutions enterprise alongside nearly 7,000 dedicated colleagues who are passionate about providing high-quality, affordable care to more than 92 million people across the United States. Under Kamal’s leadership, Prime is committed to delivering best-in-class pharmacy benefit products, market-leading specialty pharmacy solutions and clinical programs, and high-quality services and expertise across commercial, Medicare, Medicaid and exchange programs. As part of the company’s commitment to innovation, Prime is laser focused on changing health care for the better through a connected, values-driven partnership that puts people and their health first.  

Kamal joined Prime through the company’s successful merger with Magellan Rx Management, where he had served as CEO since 2015. Kamal was instrumental in shaping the agreement that united Prime and Magellan Rx in December 2022, creating a next-generation pharmacy solutions company. After the merger, he continued as CEO of Magellan Rx and joined the Prime Therapeutics executive leadership team, first as executive vice president and then as president. 

During his tenure as CEO of Magellan Rx, Kamal led the company through a period of significant growth, transformation and diversification, which positioned Magellan Rx Management as a market leader in specialty drug management, state government pharmacy solutions and middle-market pharmacy benefit management (PBM) solutions. 

Earlier in his career, Kamal served as senior vice president and general manager of Magellan Rx Management’s specialty pharmacy business, delivering industry-leading strategies and solutions to help clients successfully manage complex specialty pharmaceuticals in one of the fastest growing areas of health care spending. He also served as chief underwriting officer, directing the organization’s overall pricing, analytics and risk management strategies, and developing financial solutions to help clients manage their pharmacy spend. 

Prior to his time at Magellan Rx, Kamal held various roles with Medco Health Solutions, Inc. (now Express Scripts) with responsibility for pricing, underwriting, strategy and Medicare Part D products and services. Additionally, he worked with clients to develop strategies to address health care reform and associated product offerings to ensure clients were successfully positioned in the changing landscape. 

Kamal received his Bachelor of Science degree in economics from Rutgers University in New Brunswick, New Jersey.